Possibilities for the use of hydroxychloroquine for pre- and postexposure prophylaxis of SARS-CoV-2 infection among exposed contacts and healthcare personnel
There currently exists no published robust data which would confirm effectiveness and safety of hydroxychloroquine in pre- and postexposure prophylaxis of SARS-CoV-2 infection. Taking into account in vitro data, which indicates inhibitory activity of hydroxychloroquine against SARS-CoV-2, and interi...
Main Authors: | V. A. Otdelenov, A. V. Krykov, D. A. Sychev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2020-10-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/533 |
Similar Items
-
Change of opinion on the use of hydroxychloroquine for COVID-19 treatment and prevention
by: K. B. Mirzaev, et al.
Published: (2020-10-01) -
Adjusting the role of hydroxychloroquine with or without azithromycin in patients with COVID-19
by: V. A. Otdelenov, et al.
Published: (2020-10-01) -
What are the indications for combined use of hydroxychloroquine and lopinavir/ritonavir, and how should treatment safety monitoring be performed?
by: Yu. Yu. Kiselev, et al.
Published: (2020-10-01) -
Anticoagulant deprescribing algorithm in patients with COVID-19 after hospital discharge
by: A. V. Krykov, et al.
Published: (2020-10-01) -
Possibilities for the use of anakinra in COVID-19
by: V. A. Otdelenov, et al.
Published: (2020-10-01)